Original article by Jessica Gardner
The Australian Financial Review – Page: 1 & 8 : 24-Nov-14

The Australian Government will gain $A5.7bn from the sale of Medibank Private, after the institutional bookbuild price was set at $A2.15 per share. Jan van der Schalk of CLSA values the health fund at between $A1.55 and $A1.64 per share, noting that Medibank’s management will face a lot of pressure to achieve results due to the high issue price for the stock. Retail investors will pay $A2 per share for Medibank stock, which will debut on the sharemarket on 25 November 2014

CORPORATES
MEDIBANK PRIVATE LIMITED – ASX MPL, CLSA AUSTRALIA PTY LTD, ARGO INVESTMENTS LIMITED – ASX ARG, AUSTRALIA. DEPT OF FINANCE, AUSTRALIAN ETHICAL INVESTMENT LIMITED – ASX AEF, JAPARA HEALTHCARE LIMITED – ASX JHC, NIB HOLDINGS LIMITED – ASX NHF, RAMSAY HEALTH CARE LIMITED – ASX RHC, HEALTHSCOPE LIMITED – ASX HSO